David M. Segal

David M. Segal's AcademicInfluence.com Rankings

David M. Segal

Biology

#12067

World Rank

#15517

Historical Rank

Immunology

#800

World Rank

#823

Historical Rank

biology Degrees

Download Badge

Biology

David M. Segal's Degrees

PhD Immunology Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is David M. Segal Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David M. Segal's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 (2002) (850)
Leucine-rich repeats and pathogen recognition in Toll-like receptors. (2003) (748)
Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA (2008) (688)
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1 (2002) (680)
Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells1 (2001) (678)
L-arginine metabolism in myeloid cells controls T-lymphocyte functions. (2003) (591)
The structural biology of Toll-like receptors. (2011) (534)
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice1 (2003) (533)
The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. (1974) (402)
The molecular structure of the Toll-like receptor 3 ligand-binding domain. (2005) (391)
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. (2002) (374)
Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. (2001) (366)
TLR9 Is Localized in the Endoplasmic Reticulum Prior to Stimulation (2004) (356)
Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody (1985) (336)
Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. (1977) (334)
Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies (1996) (312)
Evidence for an Accessory Protein Function for Toll-Like Receptor 1 in Anti-Bacterial Responses1 (2000) (310)
Controlling the Toll road to dendritic cell polarization (2004) (261)
Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4 (2001) (260)
The TLR3 signaling complex forms by cooperative receptor dimerization (2008) (250)
Texas Red, a hydrophilic, red-emitting fluorophore for use with fluorescein in dual parameter flow microfluorometric and fluorescence microscopic studies. (1982) (248)
Analysis of TLR4 Polymorphic Variants: New Insights into TLR4/MD-2/CD14 Stoichiometry, Structure, and Signaling1 (2006) (239)
The dsRNA binding site of human Toll‐like receptor 3 (2006) (233)
Three-dimensional structure of immunoglobulins. (1975) (208)
TLR3-Specific Double-Stranded RNA Oligonucleotide Adjuvants Induce Dendritic Cell Cross-Presentation, CTL Responses, and Antiviral Protection (2011) (195)
Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes1 (2000) (182)
Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies (1984) (164)
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. (1997) (161)
Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors. (1971) (154)
Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors. (1977) (149)
A Complex of Soluble MD-2 and Lipopolysaccharide Serves as an Activating Ligand for Toll-like Receptor 4* (2004) (133)
Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein (1999) (129)
Human K/natural killer cells targeted with hetero-cross-linked antibodies specifically lyse tumor cells in vitro and prevent tumor growth in vivo. (1987) (128)
Targeted adenovirus-mediated gene delivery to T cells via CD3 (1997) (125)
The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding. (1984) (112)
Dendritic Cell Modulation by Mast Cells Controls the Th1/Th2 Balance in Responding T Cells1 (2006) (110)
Independent evolution of HIV type 1 in different brain regions. (1999) (109)
Structure at 4.5 A resolution of a phosphorylcholine-binding fab. (1973) (104)
Cytoplasmic Targeting Motifs Control Localization of Toll-like Receptor 9* (2006) (101)
The toll-like receptor 3:dsRNA signaling complex. (2009) (99)
Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies (1986) (96)
Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice. (1987) (92)
Heat-Killed Brucella abortus Induces TNF and IL-12p40 by Distinct MyD88-Dependent Pathways: TNF, Unlike IL-12p40 Secretion, Is Toll-Like Receptor 2 Dependent (2003) (88)
Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin (1999) (88)
Targeted antigen presentation using crosslinked antibody heteroaggregates. (1987) (87)
Mechanism of binding of multivalent immune complexes to Fc receptors. 1. Equilibrium binding. (1981) (86)
The role of disulfide bonds in the assembly and function of MD-2 (2003) (83)
Cutting Edge: Histamine Inhibits IFN-α Release from Plasmacytoid Dendritic Cells (2003) (83)
On the Molecular Structure of Collagen (1969) (81)
Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody. (1986) (81)
Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies. (1995) (80)
Multiple Dimeric Forms of Human CD69 Result from Differential Addition of N-Glycans to Typical (Asn-X-Ser/Thr) and Atypical (Asn-X-Cys) Glycosylation Motifs* (1997) (80)
Fc (IgG) receptors on rat basophilic leukemia cells. (1981) (79)
CD38 triggers cytotoxic responses in activated human natural killer cells. (1999) (79)
Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)1 (2000) (79)
Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model. (1991) (71)
CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. (1994) (70)
Icam ‐ melanoma cells are relatively resistant to cd3‐mediated t‐cell lysis (1990) (70)
Dimerization of Toll-like Receptor 3 (TLR3) Is Required for Ligand Binding* (2010) (70)
Mammalian expression and secretion of functional single-chain Fv molecules. (1994) (68)
HIV-1 infection induces a selective reduction in STAT5 protein expression. (1998) (68)
[25] Protein crystallization: Micro techniques involving vapor diffusion (1971) (67)
Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. (2006) (66)
Enhanced antigen immunogenicity induced by bispecific antibodies (1990) (65)
Linguistic complexity of protein sequences as compared to texts of human languages. (1996) (64)
The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells. (1978) (64)
Bispecific antibodies and targeted cellular cytotoxicity. (1991) (62)
Mechanism of binding of multivalent immune complexes to Fc receptors. 2. Kinetics of binding. (1981) (62)
Physical chemical studies on proteins and polypeptides. (1966) (61)
Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. (1989) (61)
Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth. (1991) (59)
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. (1997) (59)
Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule. (1994) (56)
Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. (1972) (55)
A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A . (1972) (55)
Polymers of tripeptides as collagen models. VII. Synthesis and solution properties of four collagen-like polyhexapeptides. (1969) (54)
Targeted cytotoxic cells in human peripheral blood lymphocytes. (1990) (53)
Targeting of cytotoxic cells with heterocrosslinked antibodies. (1988) (53)
Tyrosine-containing activation motif-dependent phagocytosis in mast cells. (1994) (52)
Distinct intracytoplasmic sequences are required for endocytosis and phagocytosis via murine Fc gamma RII in mast cells. (1993) (52)
Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria. (1995) (50)
Activation of murine T lymphocytes with monoclonal antibodies: detection on Lyt-2+ cells of an antigen not associated with the T cell receptor complex but involved in T cell activation. (1987) (50)
Quantitative measurements of the specificity and kinetics of conjugate formation between cloned cytotoxic T lymphocytes and splenic target cells by dual parameter flow cytometry. (1985) (50)
Dimers and trimers of immunoglobulin G covalently cross-linked with a bivalent affinity label. (1976) (49)
The fate of IgE bound to rat basophilic leukemia cells. II. Endocytosis of IgE oligomers and effect on receptor turnover. (1983) (47)
Toll‐like receptor 1 inhibits Toll‐like receptor 4 signaling in endothelial cells (2002) (44)
Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation (1997) (44)
A bacterially expressed single-chain Fv construct from the 2B4 T-cell receptor. (1993) (41)
Introduction: bispecific antibodies. (2001) (41)
Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes (1991) (41)
CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. (1996) (41)
Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. (2003) (39)
Stable model immune complexes produced by bivalent affinity labeling haptens: in-vivo survival. (1979) (39)
The role of non-immune IgG in controlling IgG-mediated effector functions. (1983) (36)
Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice. (1990) (36)
Polymers of tripeptides as collagen models. VI. Synthesis and structural investigation of poly(L-alanyl-L-prolyl-glycine). (1969) (36)
Immunoglobulin structures at high resolution. (1975) (36)
The FcR-mediated endocytosis of model immune complexes by cells from the P338D1 mouse macrophage line. I. Internalization of small, nonaggregating oligomers of IgG. (1983) (36)
HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. (2000) (35)
Targeting and activation of cytotoxic lymphocytes. (1989) (34)
Bispecific antibodies reactive with the multidrug‐resistance‐related glycoprotein and CD3 induce lysis of multidrug‐resistant tumor cells (1989) (34)
Polymers of tripeptides as collagen models. 8. X-ray studies of four polyhexapeptides. (1969) (33)
Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain. (1999) (32)
Analysis of Fc (IgG) receptors on human peripheral blood leukocytes by dual fluorescence flow microfluorometry. II. Quantitation of receptors on cells that express the OKM1, OKT3, OKT4, and OKT8 antigens. (1983) (31)
Crystal structure of galactan-binding mouse immunoglobulin J539 Fab at 4.5-A resolution. (1979) (31)
Analysis of TLR 4 Polymorphic Variants : New Insights into TLR 4 / MD2 / CD 14 Stoichiometry , Structure , and Signaling 1 (2006) (29)
Signaling Pathways Regulating CD44-Dependent Cytolysis in Natural Killer Cells (1997) (29)
The molecular structure of the TLR3 extracellular domain (2006) (29)
A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL. (1996) (29)
Human leukocyte Fc (IgG) receptors: quantitation and affinity with radiolabeled affinity cross-linked rabbit IgG. (1979) (28)
The tritium-hydrogen exchange of myosin and its proteolytic fragments. (1967) (27)
The measurement of specific cell: cell interactions by dual-parameter flow cytometry. (1984) (27)
Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens (1985) (26)
Human Conjunctival Epithelial Cells Lack Lipopolysaccharide Responsiveness Due to Deficient Expression of MD2 but Respond After Interferon-γ Priming or Soluble MD2 Supplementation (2006) (26)
Fc (IgG) receptor distributions in homogeneous and heterogeneous cell populations by flow microfluorometry. (1981) (26)
Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide‐induced cell activation by binding to CD14 (2007) (26)
The FcR-mediated endocytosis of model immune complexes by cells from the P388D1 mouse macrophage line. II. The role of ligand-induced self-aggregation in promoting internalization. (1983) (26)
The stereochemistry of substrate binding to chymotrypsin A . (1972) (25)
Going both ways: bispecific antibodies and targeted cellular cytotoxicity (1990) (25)
Characterization of murine lymphocyte IgE receptors by flow microfluorometry. (1984) (25)
Quantitation of Fc receptors and surface immunoglobulin is affected by cell isolation procedures using plasmagel and ficoll-hypaque. (1978) (25)
Enhancement of Adenovirus Vector Entry into CD70-Positive B-Cell Lines by Using a Bispecific CD70-Adenovirus Fiber Antibody (2001) (25)
Quantitative analysis of Fc gamma receptors on murine spleen cell populations by using dual parameter flow cytometry. (1984) (24)
Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis. (1990) (23)
Targeted cytotoxic cells as a novel form of cancer immunotherapy. (1988) (23)
Complement fixation by model immune complexes free in solution and bound onto cell surfaces. (1979) (23)
Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains. (1985) (22)
Activation of Human T Cells Obtained Pre‐ and Post‐Interleukin‐2 (IL‐2) Therapy by Anti‐CD3 Monoclonal Antibody plus IL‐2: Implications for Combined In Vivo Treatment (1991) (22)
Dopamine transporter mRNA in autopsy studies of chronic cocaine users. (1999) (21)
Signaling pathways regulating CD44-dependent cytolysis in natural killer cells. (1997) (21)
Phagocytosis by rat peritoneal mast cells: independence of IgG Fc-mediated and C3-mediated signals. (1982) (21)
Antibody-dependent cell-mediated cytolysis (ADCC) with antibody-coated effectors: new methods for enhancing antibody binding and cytolysis. (1980) (20)
Production of Bispecific Antibodies (1995) (20)
Targeting of anti-tumor responses with bispecific antibodies. (1992) (20)
Recombinant Mouse Bcl-2(1-203) (1996) (19)
C1q binding to antibody-coated cells: predictions from a simple multivalent binding model. (1981) (19)
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure. (1995) (19)
Complement and cell-mediated lysis of haptenated erythrocytes sensitized with oligomers of rabbit IgG antibody. (1979) (18)
Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants (1984) (17)
Targeting and Activation of Cytotoxic Lymphocytes (Part 1 of 2) (1989) (17)
Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only. (1989) (17)
A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma. (1995) (16)
Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity. (1989) (16)
Analysis of Fcγ receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, Tγ cells and cells labeled with the 3A1 anti‐T cell monoclonal antibody (1982) (16)
Composition and mass of peptides released during tryptic and chymotryptic hydrolysis of myosin. (1967) (16)
Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies. (1987) (15)
Fluorescence flow cytometry in the study of lymphoid cell receptors. (1987) (15)
A nucleolar 2'-O-methyltransferase. Specificity and evidence for its role in the methylation of mouse 28 S precursor ribosomal RNA. (1991) (14)
The biologic activity of affinity cross-linked oligomers of rabbit immunogloblin G as tested by antigody-dependent cell-mediated cytolysis (ADCC). (1977) (11)
Activation of Lyt-2+ (CD8+) and L3T4+ (CD4+) T cell subsets by anti-receptor antibody. (1989) (11)
THE THREE-DIMENSIONAL STRUCTURE OF THE ANTIGEN BINDING SITE OF McPC 603 PROTEIN (1974) (10)
Enhanced in vitro lysis of human ovarian carcinomas with activated peripheral blood lymphocytes and bifunctional immune heteroaggregates. (1990) (10)
The mechanism of intercellular aggregation. I. The kinetics of the Fc gamma receptor-mediated aggregation of P388D1 cells with antibody-coated lymphocytes at 4 degrees C. (1984) (10)
Alternative triggering molecules and single chain bispecific antibodies. (1995) (10)
Cytokine Release by Peripheral Blood Lymphocytes Targeted with Bispecific Antibodies, and Its Role in Blocking Tumor Growth (1991) (9)
X‐RAY DIFFRACTION AND ELECTRON MICROSCOPE STUDIES ON A CRYSTALLINE HUMAN IMMUNOGLOBULIN (1971) (9)
Brain macrophage surface marker expression with HIV-1 infection and drug abuse: a preliminary study. (2003) (9)
Targeting of cytotoxic cells with cross-linked antibody heteroaggregates. (1986) (9)
The specificity of interaction between S-adenosyl-L-methionine and a nucleolar 2'-O-methyltransferase. (1989) (8)
Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets. (1989) (8)
Antibody-dependent, cell-mediated cytolysis (ADCC) with antibody-coated effectors: rat and human effectors versus tumor targets. (1981) (8)
Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures. (1999) (8)
The molecular structure of the TLR3 extracellular domain. (2006) (8)
Identification of a Proposed NK Receptor (1989) (7)
A modification of space-filling atomic models allowing rapid and accurate assembly of polypeptide conformations (1966) (7)
Bispecific antibodies in cancer therapy. (1999) (6)
Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo (1995) (6)
Interaction of the Third Component of Human Complement (C3) with Erythrocytes and Leukocytes (1978) (6)
Targeted cytokine production. (1992) (6)
Predicting Toll-like receptor structures and characterizing ligand binding. (2009) (6)
Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy (1992) (6)
Designing HIV gp120 peptide vaccines: rhetoric or reality for neuro-AIDs. (2009) (6)
Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies. (1988) (5)
Measurement of Intercellular Conjugates by Flow Cytometry (2004) (5)
An em study of phosphorylcholine-binding fab immunoglobulin fragment crystals. (1975) (5)
Novel tetrameric tip motifs (APGK and VPGK) in the V3 loop of HIV type 1 envelope sequences in blood and brain from two injection drug users in Miami, Florida. (1997) (5)
Targeted Cellular Cytotoxicity (1993) (5)
Processing fate of protein antigen attached to IgD or MHC molecules on normal B lymphocytes using heterocrosslinked bispecific antibodies. (1991) (4)
Effectors of targeted cellular cytotoxicity. (1990) (4)
Cells Signaling Pathways Regulating CD 44-Dependent Cytolysis in Natural Killer (1997) (3)
Analysis of Fc gamma receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, T gamma cells and cells labeled with the 3Al anti-T cell monoclonal antibody. (1982) (3)
Human T-Lymphocytes Targeted against an Established Human Ovarian Carcinoma with a BÂ¡specific F(ab')2 Antibody Prolong Host Survival in a (1991) (3)
Refocusing the immune system to react with human tumors by targeting human lymphocytes with bispecific antibodies. (1990) (3)
SPDP Crosslinking of Antibodies to Form Heteroconjugates Mediating Redirected Cytotoxicity (1993) (3)
IMMUNOBIOLOGY CD 38 Triggers Cytotoxic Responses in Activated Human Natural Killer Cells (1999) (2)
Toll-Like Receptor 2 Dependent Pathways : TNF , Unlike IL-12 p 40 Secretion , Is IL-12 p 40 by Distinct MyD 88-Dependent Induces TNF and Brucella abortus Heat (2003) (2)
Phagocytosis by rat mast cells: Independence of IGG FC-mediated and C3b-mediated signals (1982) (1)
Seasonal and Pandemic Influenza Surveillance and Disease Severity (2015) (1)
Monocytes and Dendritic Cells Regulation of Toll-Like Receptors in Human (2000) (1)
Mast Cell Degranulation Inhibits Th1 and Promotes Th2 Responses (2008) (1)
Human T Cells Targeted with Hetero‐cross‐linked Antibodies Prevent Tumor Growth in Nude Mice (1988) (1)
Comparison of the ability of red cells sensitized with a bispecific anti-D × anti-FcγRIII Fab fragment to activate human K cells and peritoneal macrophages through FcγRIII (1994) (1)
Crystal structure of mouse TLR3 ectodomain (2008) (0)
Lymphocytes Trigger Apoptosis in Antigen-Activated T Immortalized Myeloid Suppressor Cells and (2000) (0)
Dopamine Transporter mRNA in Human Brain Distribution and Regulatory Effects in Autopsy Studies of Cocaine Abusers (2012) (0)
Redirection of cellular cytotoxicity (1995) (0)
Crystals of phosphorylcholine-binding mouse myeloma fab' fragments suitable for high resolution x-ray crystallographic analysis. Abstr. (1972) (0)
Targeting and Activation of Cytotoxic Lymphocytes (Part 2 of 2) (1989) (0)
Structure of a phosphorycholine-binding mouse myeloma Fab. (1975) (0)
Subclass specificity for the binding of murine myeloma proteins to cells bearing fc receptors. Abstr. (1977) (0)
Double-Stranded RNA Structural Basis of Toll-Like Receptor 3 Signaling with (2014) (0)
Dopamine Transporter mRNA in Human Brain (2000) (0)
Crystal structure of galactan-binding mouse immunoglobulin J 539 Fab at 4 . 5-A resolution ( x-ray diffraction / pattern recognition / antibody structure ) (0)
Cells CD38 Triggers Cytotoxic Responses in Activated Human Natural Killer (2013) (0)
Mast cells are critical for the degranulation‐induced shift from Th1 to Th2 immune responses in vivo (2008) (0)
Stoichiometry, Structure, and Signaling New Insights into TLR4/MD-2/CD14 Analysis of TLR4 Polymorphic Variants: (2013) (0)
Antiviral Protection Cell Cross-Presentation, CTL Responses, and Oligonucleotide Adjuvants Induce Dendritic TLR3-Specific Double-Stranded RNA (2011) (0)
Nomenclature of the Fc receptors (1998) (0)
Socioepidemiology of Injection Drug Users in Miami and HIV-1B Envelope (V1–V5) Genetic Diversity: A Preliminary Study (2017) (0)
The role of antibody multivalency in immune effector processes. (1980) (0)
1688 EFFECTOR CELLS PRODUCED BY HETEROAGGREGATED ANTIBODIES (2003) (0)
Histamine modulates the polarizing activities of human dendritic cells (2003) (0)
Mouse Toll-like receptor 3 ectodomain complexed with double-stranded RNA (2008) (0)
9 Cellular Cytotoxicity (1993) (0)
The Three Dimensional Structure of a Phosphorylcholine-Binding Mouse Immunoglobulin Fab and the Nature of the Antigen Binding Site ( x-ray diffraction / domain structure / hypervariable cavity / hapten binding / antibody diversity ) (0)
CTLA-4 (CD152) Surface-Linked Single-Chain Antibody to Blockade of T Cell Activation Using a (2000) (0)
Reduction in STAT5 Protein Expression Cutting Edge: HIV-1 Infection Induces a Selective (1997) (0)
Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII. (1994) (0)
Myeloma proteins, preparation and x-ray analysis. (1972) (0)
Responsesfor Toll-Like Receptor 1 in Anti-Bacterial Evidence for an Accessory Protein Function (2000) (0)
Viral and host determinants of neurovirulence of HIV-1 infection. (1998) (0)
The Use of Flow Cytometry in the Study of Intercellular Aggregation (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David M. Segal?

David M. Segal is affiliated with the following schools:

University of Central Florida

David M. Segal's Academic­Influence.com Rankings